Your browser doesn't support javascript.
loading
Chromosomal abnormalities and neurological outcomes in fetal cerebral ventriculomegaly: a retrospective cohort analysis.
Lok, W Y; Kong, C W; Hui, S Y A; Shi, M M; Choy, K W; To, W K; Leung, T Y.
Afiliación
  • Lok WY; Department of Obstetrics and Gynaecology, United Christian Hospital, Hong Kong.
  • Kong CW; Department of Obstetrics and Gynaecology, United Christian Hospital, Hong Kong.
  • Hui SYA; Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong.
  • Shi MM; Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong.
  • Choy KW; Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong.
  • To WK; Department of Obstetrics and Gynaecology, United Christian Hospital, Hong Kong.
  • Leung TY; Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong.
Hong Kong Med J ; 27(6): 428-436, 2021 12.
Article en En | MEDLINE | ID: mdl-34949731
ABSTRACT

INTRODUCTION:

This study investigated the incidences of chromosomal abnormalities and the neurological outcomes according to the degree of fetal cerebral ventriculomegaly.

METHODS:

All women with antenatal ultrasound diagnosis of fetal cerebral ventriculomegaly were retrospectively identified from two maternal-fetal medicine units in Hong Kong from January 2014 to December 2018. Degrees of fetal ventriculomegaly were classified as mild (10-11.9 mm), moderate (12-14.9 mm), or severe (≥15 mm). Genetic investigation results were reviewed, including conventional karyotyping and chromosomal microarray analysis (CMA); correlations between chromosomal abnormalities and the degree of fetal ventriculomegaly were explored. The neurological outcomes of subsequent live births were analysed to identify factors associated with developmental delay.

RESULTS:

Of 84 cases (ie, pregnant women and their fetuses) included, 46 (54.8%) exhibited isolated fetal ventriculomegaly, 55 (65.5%) had mild cerebral ventriculomegaly, and 29 (34.5%) had moderate or severe cerebral ventriculomegaly. Overall, 20% (14/70) of cases had chromosomal abnormalities. Moreover, 12% (3/25) of mild isolated ventriculomegaly cases had abnormal karyotype or CMA results. The CMA provided an incremental diagnostic yield of 8.6% (6/70), compared with conventional karyotyping; 4.3% exhibited pathogenic variants and 4.3% exhibited variants of uncertain significance. Among the 53 live births in the cohort, fewer cases of mild isolated ventriculomegaly were associated with developmental delay than more severe isolated ventriculomegaly (9.7% vs 41.7%, P<0.03).

CONCLUSIONS:

Chromosomal microarray analysis testing should be offered to all women with fetal cerebral ventriculomegaly, including women with isolated mild ventriculomegaly. The incidence of developmental delay after birth increases with the degree of prenatal cerebral ventriculomegaly.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aberraciones Cromosómicas / Hidrocefalia Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: Hong Kong Med J Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Hong Kong

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aberraciones Cromosómicas / Hidrocefalia Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: Hong Kong Med J Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Hong Kong